Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
cubn amn pathway loss in chronic benign proteinuria
Original title: “CUBN-AMN pathway loss in chronic benign proteinuria.”
impact immune monitoring and phenotype assessment of clinical trajectory for patients with inborn errors of immunity from the primary immune deficiency treatment consortium pidtc
Original title: “IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC).”
expansion of pathogens and restoration of human skin microbiome in cd4 t cell lymphopenia
Original title: “Expansion of pathogens and restoration of human skin microbiome in CD4 T-cell lymphopenia.”
hsd17b7 is required for the function of sensory hair cells by regulating cholesterol synthesis
Original title: “HSD17B7 is required for the function of sensory hair cells by regulating cholesterol synthesis.”
patterns of progression and clinical outcomes after first progression in patients with primary plasma cell leukemia
Original title: “Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.”
pathology illustrates pathogenesis of indium lung diseases in rats induced by indium tin oxide nanoparticles
Original title: “Pathology illustrates pathogenesis of indium lung diseases in rats induced by indium-tin oxide nanoparticles.”
whipple s endocarditis and biologic response modifiers a case based review of an intricate host pathogen interaction
Original title: “Whipple's endocarditis and biologic response modifiers: a case-based review of an intricate host-pathogen interaction.”
treatment of acute m3 thrombosis
Original title: “Treatment of Acute M3 Thrombosis.”
hypoxia activated photomolecular glue with synergistic cyclin k degradation and phototherapy for cancer treatment
Original title: “A Hypoxia-Activated Photomolecular Glue with Synergistic Cyclin K Degradation and Phototherapy for Cancer Treatment.”
extranodal rosai dorfman disease with bilateral renal involvement a diagnostic challenge
Original title: “Extranodal Rosai-Dorfman disease with bilateral renal involvement: A diagnostic challenge.”
igg4 related hepatic inflammatory pseudotumor with extensive portal vein thrombosis mimicking hepatocellular carcinoma
Original title: “IgG4-Related Hepatic Inflammatory Pseudotumor With Extensive Portal Vein Thrombosis Mimicking Hepatocellular Carcinoma.”
modelling the effect of v1a receptor antagonism and its potential therapeutic effect in circadian disorders
Original title: “Modelling the effect of V1a receptor antagonism and its potential therapeutic effect in circadian disorders.”
mri end points for clinical trials in ataxias recommendations from the ataxia global initiative mri biomarkers working group
Original title: “MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group.”
rare case of malignant transformation in bilateral phyllodes tumor leading to osteosarcomatous metastases
Original title: “A Rare Case of Malignant Transformation in Bilateral Phyllodes Tumor Leading to Osteosarcomatous Metastases.”
intravenous thrombolysis in acute mild non disabling ischemic stroke a retrospective cohort study
Original title: “Intravenous thrombolysis in acute mild non-disabling ischemic stroke: A retrospective cohort study.”
cytokeratin positive pleomorphic chest wall sarcoma mimicking mpnst a case report
Original title: “Cytokeratin-Positive Pleomorphic Chest Wall Sarcoma Mimicking MPNST: A Case Report.”
When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in a mid-stage trial of advanced melanoma—a result analysts said could help “instill confidence” in the regimen.
Original title: “ASCO: Moderna’s mRNA-based melanoma vaccine shows ‘encouraging’ 5-year survival”
At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.
Original title: “ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer”